Allergan: Gains on Botox for Migraines Ease ER LoadDrug Pitched as Cost Saver for Managed Care Insurers Sunday, May 29, 2011
Agendia in Cancer Project
Agendia BV, a Dutch laboratory with U.S. headquarters in Irvine, is working with British drug maker AstraZeneca PLC and the Netherlands Cancer Institute to develop a targeted therapy for colorectal cancer patients.
Agendia will provide molecular data, bioinformatics and diagnostic support for AstraZeneca to identify subgroups within colorectal cancer. Agendia said it will provide the information for research and development of medicines suited to individual disease types.
“Researchers have known for some time that there are different subtypes of colorectal cancer,” said George Orphanides, head of AstraZeneca’s colorectal cancer disease area.
Agendia is known for developing MammoPrint, a test to determine recurrence of breast cancer.
Auxilio Inc., a Mission Viejo company that helps hospitals and other healthcare providers cut their dependence on paper records, said it signed a five-year contract with Fountain Valley-based MemorialCare Health System.
The contract is valued at $16 million to $18 million, according to Auxilio. It includes MemorialCare’s corporate headquarters, the Memorial Medical Center Foundation, Long Beach Memorial Medical Center and Miller Children’s Hospital in Long Beach.
The contract extends work that Auxilio already is doing at Saddleback Memorial Medical Center campuses in Laguna Hills and San Clemente, and Orange Coast Memorial Medical Center in Fountain Valley.
Bits and Pieces
The Orange County chapter of the Healthcare Businesswomen’s Association recently hosted a discussion on accountable care organizations, a feature of federal healthcare reform that aims to reduce healthcare costs and improve patients’ health. Panelists included Greater Newport Physicians IPA in Newport Beach and Monarch HealthCare of Irvine. Monarch is participating in a federal trial program of accountable care organizations … NextGen Healthcare Information Systems Inc., a subsidiary of Irvine healthcare software maker Quality Systems Inc., said Rye Brook, N.Y.-based Universal American Corp., will use its NextGen Ambulatory electronic health record software. Universal offers health benefits to people on Medicare.